Back to search

Article

BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancer

2024-05-10

Abstract excerpt

<h4>Background</h4> Triple-negative breast cancer (TNBC) is a highly aggressive form of breast cancer subtype often treated with radiotherapy (RT). Due to its intrinsic heterogeneity and lack of effective targets, it is crucial to identify novel molecular targets that would increase RT efficacy. Here we demonstrate the role of BUB1 (cell cycle Ser/Thr kinase) in TNBC radioresistance and offer a novel strategy to...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
f1aab72f-d74e-54eb-8f0d-66852174c3cc
DOI
10.1101/2024.05.07.592812
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
BUB1 regulates non-homologous end joining pathway to mediate radioresistance in triple-negative breast cancerDOI 10.1101/2024.05.07.592812
Select a neighboring publication to make it the new centre.